A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I.
Zmetakova I, et al. Among authors: horvathova kajabova v.
Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18.
Cancer Sci. 2019.
PMID: 30815959
Free PMC article.